Bispecific antibodies (anti-mPEG/anti-HER2) for active tumor targeting of docetaxel (DTX)-loaded mPEGylated nanocarriers to enhance the chemotherapeutic efficacy of HER2-overexpressing tumors

Chia-Yu Su (Contributor)
Michael Chen (Contributor)
Ling Chun Chen (Contributor)
Yuan-Soon Ho (Contributor)
Hsiu-O Ho (Contributor)
Shyr-Yi Lin (Contributor)
Kuo-Hsiang Chuang (Contributor)
Ming-Thau Sheu (Contributor)

Dataset

1 Article

1 results

2018
Bispecific antibodies (anti-mPEG/anti-HER2) for active tumor targeting of docetaxel (DTX)-loaded mPEGylated nanocarriers to enhance the chemotherapeutic efficacy of HER2-overexpressing tumors
Su, C. Y., Chen, M., Chen, L. C., Ho, Y. S., Ho, H. O., Lin, S. Y., Chuang, K. H. & Sheu, M. T., Nov 1 2018, In: Drug Delivery. 25, 1, p. 1066-1079 14 p.
Research output: Contribution to journal › Article › peer-review
19 Citations (Scopus)